When

Wednesday, August 21, 2019 from 11:30 AM to 1:00 PM EDT
Add to Calendar 

Where

Tangier's 
532 W. Market St.
Akron, OH 44303
 

 
Driving Directions 

Contact

Sally Cox 
Summit County Safety Council 
330-806-1676 
summitcountysafetycouncil@gmail.com 
 

Safety Council Meeting - August 21, 2019 

 

 

White Powder Mail Threat

Bryan Seamour

Special Agent, Weapons of Mass Destruction Coordinator

FBI Cleveland Division

 

Agent Seamour's presentation will include a basic level understanding of the white powder letter/threat mailings that have recently re-surfaced, including:
  • Current trends in these WPL mailings
  • FBI's role in the response/investigations
  • Threat Credibility Evaluation (TCE)
  • Hazmat response
  • Evidence collection
  • Employee responsibility
  • Public Health's role
  • Local LE response/role
  • Laboratory Response Network (LRN)
  • Suspicious package identification
About Bryan

Special Agent Bryan Seamour is Cleveland FBI's Weapons of Mass Destruction Coordinator. He focuses on mitigating emerging WMD threats in the chemical, biological, radiological and nuclear modalities through preparedness, implementing countermeasures, conducting investigations, operations, and intelligence gathering via extensive liaison with other federal/state and local partners. These include academia, private industry, law enforcement, public health, fire/EMS, EMA, Civil Support Teams, etc. Bryan is assigned to Cleveland FBI’s Domestic Terrorism squad and is a member of the Joint Terrorism Task Force (JTTF). He assisted in several National Special Security Events (Papal Visit, RNC, DNC, Inauguration, U.N. General Assembly) in a WMD operational role as well as numerous SEAR 1-2 rated special events (Super Bowl, All-Star Game, Boston Marathon, etc.)
 
Bryan is a 1992 graduate of Ohio State University with a B.S. in Food Science & Nutrition. He received his Ph.D. in 1998 from the Institute of Biomedical Studies at Baylor University (TX). Majoring in Molecular Biology and Immunology, his research focused on genetic transformation of hematopoietic disease malignancies (multiple myeloma, leukemia, and lymphoma).